Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.

O'Connor P, Comi G, Freedman MS, Miller AE, Kappos L, Bouchard JP, Lebrun-Frenay C, Mares J, Benamor M, Thangavelu K, Liang J, Truffinet P, Lawson VJ, Wolinsky JS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas.

Neurology. 2016 Mar 8;86(10):920-30. doi: 10.1212/WNL.0000000000002441. Epub 2016 Feb 10. Erratum in: Neurology. 2016 Oct 4;87(14 ):1524.

2.

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.

Wolinsky JS, Narayana PA, Nelson F, Datta S, O'Connor P, Confavreux C, Comi G, Kappos L, Olsson TP, Truffinet P, Wang L, Miller A, Freedman MS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group.

Mult Scler. 2013 Sep;19(10):1310-9. doi: 10.1177/1352458513475723. Epub 2013 Feb 27.

PMID:
23447359
3.

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group.

N Engl J Med. 2011 Oct 6;365(14):1293-303. doi: 10.1056/NEJMoa1014656.

4.

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators.

Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5.

PMID:
21975206
5.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group.

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
6.

Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis.

Boon M, Nolte IM, Bruinenberg M, Spijker GT, Terpstra P, Raelson J, De Keyser J, Zwanikken CP, Hulsbeek M, Hofstra RM, Buys CH, te Meerman GJ.

Neurogenetics. 2001 Oct;3(4):221-30.

PMID:
11714103
7.

Health care utilization by people with multiple sclerosis in The Netherlands: results of two separate studies.

Moorer P, Suurmeijer TH, Zwanikken CP.

Disabil Rehabil. 2000 Nov 10;22(16):695-701.

PMID:
11117589
8.

Space-time clustering of multiple sclerosis cases around birth.

van Buuren S, Zaadstra BM, Zwanikken CP, Buljevac D, van Noort JM.

Acta Neurol Scand. 1998 Jun;97(6):351-8.

PMID:
9669466
9.

A patient with vertebrobasilar transient ischaemic attacks and provokable basilar steal.

Zwanikken CP, van der Windt JM, Bast TJ, Boezeman EH, Ackerstaff RG.

Clin Neurol Neurosurg. 1990;92(4):369-72.

PMID:
1963832
10.

Chronic epidural haematoma. A non-typical course of extradural haemorrhage.

Corraddu M, Matricali B, Zwanikken CP.

Clin Neurol Neurosurg. 1984;86(2):115-8.

PMID:
6329577

Supplemental Content

Loading ...
Support Center